STC.UNM : Welcome!

Angels seek Deals
April 7, 2008
New Mexico Angels, a nine-year-old group of private investors who informally invest together in small tech firms is looking for more deals. more

Other recent stories:

Angels and academics (March 28, 2008)
Cerner Corp. funds research on UNM drug inhaler (March 14, 2008)
Cerner and UNMHSC sign agreement to evaluate dry-powder inhaler drug-delivery technology (March 13, 2008)

More...

Upcoming events include:

BIOMEDICAL TUESDAY...in Albuquerque
May 13, 2008 / 11:30am / Science and Technology Park, Rotunda Room, 801 University Blvd. SE, East end of building
Presented by Denise Brown, Executive Director
Part of the Commercialization Seminars more

More...

Technology Email Alerts

Spring 2008 Newsletter (3.95Mb)
Invention and Patent at UNM (6.64Mb)

Log-in to My Technologies
Submit Your Disclosure Online

New or modified technologies over the past four weeks include:

Caspase-Mediated Apoptosis in a Human Fibrosarcoma Cell Line (ref. STC-LS-0400)
Biomarker of Schizophrenia in Cerebral Spinal Fluid (ref. STC-LS-0102)
Chiral Amine Catalyzed Enantioselective Cascade Aza-ene-type Aldol Reactions Catalysts (ref. STC-PS-0880)
Organocatalytsts and Methods for the Preparation of Chiral Compounds (ref. STC-PS-0833)
Two Piece Airway Mask (ref. STC-LS-0381)
Self Supporting Structurally Engineered Non-platinum Electrocatalyst (ref. STC-PS-0765)
A Compound for the Maintenance of Prostate Health and the Treatment of Prostatic Disorders (ref. STC-LS-0357)
Compound for Treatment of TB (ref. STC-LS-0378)
Extended Viability Vaccines for TB (ref. STC-LS-0401)
Improved Tuberculosis Vaccine (ref. STC-LS-0406)
Lead Compounds and Method for Discovering Lead Compounds for the Inhibition of Anti-Apoptotic Bcl-2 Family of Proteins (ref. STC-LS-0377)
Peptide Radiopharmaceuticals for Melanoma Detection and Therapy (ref. STC-LS-0396)
Thiourea for Catalytic Reactions (ref. STC-PS-0824)

More...

We are a nonprofit corporation formed by and owned entirely by the University of New Mexico (UNM) to protect and transfer its faculty inventions to the commercial marketplace. We license innovative technology developed at UNM, including optics, microfluidics, and high performance materials as well as therapeutics, diagnostics, medical devices, and drug discovery tools.

More...


	Copyright © 2007 STC.UNM. All rights reserved.	Contact Us